The bioinformatics company Proacta, listed on NewConnect, recorded a revenue increase to PLN 1.7 million in the third quarter. Following the success of the series N share issue and the acquisition of over PLN 2 million from investors, the company is now implementing further investments to develop and promote the ‘I Take Care of Myself Smart LAB’ platform, which is seeing increasing interest from users. Proacta has made significant business strides in the healthcare sector, establishing numerous collaborations, including with Medidesk, the Medical Education Centre, and signing letters of intent with the World Hearing Centre and the University Centre for Women’s and Newborn’s Health. In the future, the company also plans to further develop its innovative solutions, including through funds from the National Recovery Plan (NRP).
“We are consistently working towards increasing the scale of operations in the area of the Company’s proprietary products. Currently, we are focusing on improving our key product – the ‘I Take Care of Myself Smart LAB’ platform, from which we recorded our first revenue in the reported quarter. The investments related to the expansion of this platform and depreciation costs had a significant impact on the company’s financial results achieved in 2024. Nevertheless, with the development of our proprietary products and the continuation of the implementation of the concluded agreements, including subcontracting contracts for state organisations, profitability will significantly increase, thereby improving the financial results achieved in subsequent periods,” informs Arkadiusz Zachwieja, Vice President of the Management Board of Proacta S.A.
Proacta S.A. generated revenue of PLN 1.7 million from July to September this year, compared to zero revenue in the same period the previous year. Cumulatively in 2024, the company’s revenue exceeded PLN 4.6 million, compared to marginal results recorded in 2023. In the third quarter, Proacta S.A. reported a loss of over PLN 0.5 million, directly affected by depreciation costs amounting to a total of PLN 0.57 million.
In the third quarter, Proacta achieved significant business and development goals. In early July, the company launched the ‘I Take Care of Myself Smart LAB’ platform, classified as a medical device, which supports patients in analysing laboratory test results. The company raised over PLN 2 million from investors for further development and promotion of the platform as part of the series N share issue. Currently, a marketing and sales campaign targeting potential users (patients) is underway.
In July, Proacta also signed a framework agreement with Medidesk, whose solutions are used by nearly 700 medical facilities. The strategic cooperation will include support in sales and the promotion of Proacta products and services for B2B customers.
Proacta S.A.’s analytical solutions using AI tools have attracted the interest of renowned medical institutions. At the turn of July and August, Proacta signed letters of intent for future cooperation with the World Hearing Centre and the University Centre for Women’s and Newborn’s Health. The potential cooperations include the preparation and implementation of projects based on data analysis technology developed by Proacta.
At the beginning of August, Proacta announced the signing of a three-year agreement by its subsidiary Ve Space Sp. z o.o. with the Medical Education Centre to provide a platform for organising online events, based on the proprietary ‘Ve Space’ solution. The value of the agreement will exceed PLN 1.6 million, excluding additional services that may be ordered during the implementation of the agreement.
During this time, Euvic, one of the largest technology groups in Poland, announced the acquisition of over 10% of shares in Proacta S.A.
“The past few months have been key to Proacta’s development in the healthcare sector. We have established extremely important collaborations with partners and launched the ‘I Take Care of Myself Smart LAB’ platform. Our promotional campaign is delivering very good results and high conversion rates, which translates into a significant increase in users on the site. I expect that we will steadily increase our presence not only on the domestic market, but also on the international arena, in response to the growing demand for advanced solutions for the medical sector. As part of our ongoing activities, we intend to fully exploit the potential of the National Recovery Plan (NRP), which provides substantial funds for the development of innovative solutions in the field of healthcare, including digitisation, artificial intelligence and bioinformatics. We are actively working to obtain these funds as part of our own projects and those implemented in cooperation with industry partners and medical entities. Our solutions perfectly fit the NRP goals, such as improving efficiency, accessibility and quality of the healthcare system and digital transformation. Thanks to the funds from the NRP, we want to develop our products and services, supporting the modernisation of Polish healthcare,” summarises Paweł Ciesielka, President of the Management Board of Proacta S.A.
Source: https://managerplus.pl/proacta-s-a-odnotowuje-dynamiczny-wzrost-przychodow-i-realizuje-kluczowe-inwestycje-w-sektorze-ochrony-zdrowia-98497
